Beromun European Union - English - EMA (European Medicines Agency)

beromun

belpharma s.a. - tasonermin - sarcoma - immunostimulants, - beromun is indicated in adults as an adjunct to surgery for subsequent removal of the tumour so as to prevent or delay amputation, or in the palliative situation, for irresectable soft-tissue sarcoma of the limbs, used in combination with melphalan via mild hyperthermic isolated-limb perfusion (ilp).